Results 211 to 220 of about 255,577 (258)

A Hydrogen Sulfide–Releasing Dynamic Hydrogel Modulates Coordinated Neurovascular, Immune, and Angiogenic Responses for Scar‐Suppressed Diabetic Wound Repair

Advanced Science, EarlyView.
ROS‐Responsive H2S Hydrogel (HAPPF) Coordinated Regeneration for High‐Quality Diabetic Wound Repair.A self‐regulating dynamic hydrogel is developed to deliver a fluorogenic H2S donor in response to excessive ROS. Released H2S acts as a master regulator to resolve chronic inflammation (M2 polarization), restore VEGF‐driven angiogenesis, and rebalance ...
Xuyang Ning, Ziqiang Zhou, Bangming Li, Hong Lu, Haoyang Wen, Zhoulong Huang, Gang Li, Ping Hu   +7 more
wiley   +1 more source

Baseline intact fibroblast growth factor 23 and risk of kidney disease progression in the Indian Chronic Kidney Disease cohort: a prospective multicenter study. [PDF]

Front Med (Lausanne)
Kamboj K, Yadav AK, Rastogi A, Ghosh A, Sharma S, Jain L, Kumar V, Jha V, Indian Chronic Kidney Disease Study Network.   +8 more
europepmc   +1 more source

Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophy. [PDF]

NPJ Metab Health Dis
Latic N, Lari A, Sun N, Zupcic A, Oubounyt M, Falivene J, Buck A, Hofer M, Chang W, Kuebler WM, Baumbach J, Walch AK, Grabner A, Erben RG.   +13 more
europepmc   +1 more source

Fibroblast growth factor-23 remodels vascular extracellular matrix via glycosaminoglycan induction: implications for calcification in chronic kidney disease. [PDF]

Ren Fail
Freise C, Jernej T, Metzkow S, Schnorr J, Taupitz M.   +4 more
europepmc   +1 more source

Increased Plasma Fibroblast Growth Factor 23 and In-hospital Acute Kidney Injury after Cardiac Surgery. [PDF]

Anesthesiology
Cheruku SR, Neyra JA, Mohammad H, Trinh J, Hernandez G, Nakonezny PA, Jessen ME, Moe OW, Fox AA.   +8 more
europepmc   +1 more source

Heterogeneous regulation of fibroblast growth factor 23 in acute kidney injury, chronic kidney disease, and polycystic kidney disease: mechanisms, diagnostic utility, and clinical implications. [PDF]

Front Mol Biosci
Hu X, Yang B, Chen H, Min M, Liu N, Xue C.   +5 more
europepmc   +1 more source

Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation. [PDF]

J Cardiovasc Dev Dis
Yared W, Dogan L, Fassli AM, Moza A, Goetzenich A, Stoppe C, Mohammed AFA, Kraemer S, Tewarie L, Abugameh A, Zayat R.   +10 more
europepmc   +1 more source

Correction to: "Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders".

Endocrinology
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibroblast growth factor 23

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2013
There is growing interest in the role of fibroblast growth factor 23 (FGF23) in various diseases of disordered mineral metabolism. In chronic kidney disease (CKD), where biochemical evidence of mineral disturbances is especially common, FGF23 measurement has been advocated as an early and sensitive marker for CKD-related bone disease.
Edward R, Smith, Lawrence P, McMahon, Stephen G, Holt   +2 more
openaire   +2 more sources